Newscope Announces Name Change

April 8, 2021
News

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (the “Company”) (CSE: PHRM) (OTCQB: PHRRF) is pleased to announce that it has filed an alteration notice with BC Registry Services changing the name of the Company to PharmaTher Holdings Ltd. The name change was approved by the Company’s shareholders at the special meeting held on April 5, 2021. The Company will be filing the necessary documentation with the CSE in order to commence trading under its new name.

There is no change in the share capital of the Company or its trading symbol, and shareholders are not required to exchange their existing share certificates for new certificates.

About Newscope Capital Corporation

Newscope Capital Corporation is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat neuropsychiatric, neurodegenerative and pain disorders.

Learn more at: PharmaTher.com and follow us on Twitter and LinkedIn.

For more information, please contact:

Fabio Chianelli
Chief Executive Officer
Newscope Capital Corporation
Tel: 1-888-846-3171
Email: info@pharmather.com
Website: www.pharmather.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.


Always do your own research and make your own investment decisions. This is not a solicitation to purchase or sell securities. Psychedelic Finance is not a registered investment advisor and does not purport to provide investment advice, whether implied or otherwise. Psychedelic Finance does not independently verify the accuracy or the truth of the statements or representations made by issuers. This message is meant for information and educational purposes only and Psychedelic Finance does not intend for this information to be used to inform an investment decision.